No menu items!

Tag: the serum’s initial clinical trial phases will be conducted only in Brazil

RIO DE JANEIRO, BRAZIL - The Brazilian Health Regulatory Agency (ANVISA) on Tuesday, May 25, authorized the start of trials of the anti-Sars-CoV-2 serum, developed by the Butantan Institute, in São Paulo. With the decision, the Butantan Institute may begin...

LATEST NEWS

WEATHER

Rio de Janeiro
overcast clouds
21 ° C
22.2 °
21 °
86 %
1.5kmh
100 %
Mon
22 °
Tue
22 °
Wed
21 °
Thu
26 °
Fri
24 °